Bristol-Myers Squibb (BMY) Announces Positive Updated Opdivo Combo Phase 1b Data in NDCLC
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced updated findings from the Phase 1b trial, CheckMate -012, in chemotherapy-naïve advanced non-small cell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE